Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system

By Nicolaides Theodore   Tihan Tarik   Horn Biljana   Biegel Jaclyn   Prados Michael   Banerjee Anuradha  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis

By Lai Gillianne Geet Yi   Koo Yu Xuan   Tao Miriam   Tan Thuan Tong   Lim Soon-Thye  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 144-145

Informa Healthcare

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma: Treatment with Chemotherapy and Radiotherapy

By Sarazin M.   Ameri A.   Monjour A.   Nibio A.   Poisson M.   Delattre J.Y.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2003-2007

Elsevier

Access to resources Recommend Favorite

Double high-dose chemotherapy and stem cell transplantation in adult Wilms’ tumor

By Kosmas Christos   Daladimos Theodoros   Athanasopoulos Aggelos   Theotikos Evangelos   Tsakonas George   Karabelis Athanasios   Mylonakis Nikolaos  

Future Oncology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1803-1809

Future Medicine

Access to resources Recommend Favorite